^SAMPLE = GSM795943!Sample_title = Sample 32P_ependymoma-250ksty!Sample_geo_accession = GSM795943!Sample_status = Public on Feb 09 2012!Sample_submission_date = Sep 13 2011!Sample_last_update_date = Feb 09 2012!Sample_type = genomic!Sample_channel_count = 1!Sample_source_name_ch1 = primary ependymoma DNA sample from patient 32!Sample_organism_ch1 = Homo sapiens!Sample_taxid_ch1 = 9606!Sample_characteristics_ch1 = patient: 32!Sample_characteristics_ch1 = disease state: ependymoma!Sample_characteristics_ch1 = ependymoma status: primary!Sample_characteristics_ch1 = gender: female!Sample_characteristics_ch1 = location: supratentorial (ST)!Sample_characteristics_ch1 = age: 11.4yrs!Sample_characteristics_ch1 = tumour grade: World Health Organisation Grade III!Sample_characteristics_ch1 = patient outcome: Alive and no disease progression!Sample_characteristics_ch1 = tumour 1q gain status: No 1q gain!Sample_molecule_ch1 = genomic DNA!Sample_extract_protocol_ch1 = Genomic DNA was extracted snap frozen tumour tissue and mononuclear cell preparations  from peripheral blood, using a standard phenol/chloroform/isoamyl alcohol method. DNA quality and quantity was assessed using a Nandrop spectrophotometer and agarose gel electrophoresis.!Sample_label_ch1 = Biotin!Sample_label_protocol_ch1 = As per manufacturer (Affymetrix)!Sample_hyb_protocol = DNA was restriction digested, PCR amplified, fragmented, labelled and hybridised to each array according to the manufacturer's instructions.!Sample_scan_protocol = The Arrays were then washed using Affymetrix fluidics stations, and scanned using the Gene Chip Scanner 3000.!Sample_description = primary ependymoma, female, ST, 11.4yrs!Sample_description = S0398FL0018 sty!Sample_description = Hybridized to 250K_Sty!Sample_data_processing = CEL files and CHP files (generated by Affymetrix GTYPE using the BRLMM algorithm) were processed by CNAG. Normalization was performed using the constitutional samples. Data processing was performed as described in Miller et al Neuro Oncol 2011;13(8):866-79.!Sample_data_processing = Primary data description: Genotype Call (SNP call): AA, AB, BB, NC, and NoCall;!Sample_platform_id = GPL3720!Sample_contact_name = John-Paul,,Kilday!Sample_contact_email = mgzjk@exmail.nottingham.ac.uk!Sample_contact_phone = 0115 8230718!Sample_contact_laboratory = D18!Sample_contact_department = CBTRC!Sample_contact_institute = University of Nottingham !Sample_contact_address = Derby Road!Sample_contact_city = Nottingham!Sample_contact_zip/postal_code = NG7 2UH!Sample_contact_country = United Kingdom!Sample_supplementary_file = ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM795nnn/GSM795943/suppl/GSM795943_S0398FL0018-250ksty.CEL.gz!Sample_supplementary_file = ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM795nnn/GSM795943/suppl/GSM795943_S0398FL0018-250ksty.brlmm.chp.gz!Sample_series_id = GSE32101!Sample_data_row_count = 238354#ID_REF = PROBE SET NAME#VALUE = CALL#CONFIDENCE = #FORCED CALL = #CONTRAST = #STRENGTH = !sample_table_beginID_REF	VALUE	CONFIDENCE	FORCED CALL	CONTRAST	STRENGTHAFFX-2315060	AB	0.004122	AB	-0.073519	12.328858AFFX-2315061	AB	0.004096	AB	0.120197	11.039031AFFX-2315062	AA	0.035659	AA	0.744472	10.242679AFFX-2315057	AB	0.025122	AB	-0.162187	10.592117AFFX-2315058	AB	0.017534	AB	0.308816	12.119139AFFX-2315059	AB	0.003613	AB	0.105801	10.986058AFFX-2315063	BB	0.031996	BB	-0.859222	11.281850AFFX-2315064	AB	0.003999	AB	0.208274	9.697618AFFX-2315065	AB	0.036001	AB	-0.090271	10.338272AFFX-2315066	BB	0.014241	BB	-0.784454	10.553655AFFX-2315067	BB	0.093503	BB	-0.566537	11.463361AFFX-2315068	BB	0.031580	BB	-0.789347	10.447711AFFX-2315069	AA	0.013206	AA	0.688720	9.772108AFFX-2315070	AB	0.010293	AB	-0.071415	10.448731AFFX-2315071	AB	0.011565	AB	-0.166195	10.641803AFFX-2315072	AA	0.030165	AA	0.794250	11.232441AFFX-2315073	AB	0.008641	AB	0.138838	10.912261AFFX-2315074	BB	0.063330	BB	-0.682503	9.744627AFFX-2315075	AB	0.005674	AB	0.115430	11.455990AFFX-2315076	BB	0.014111	BB	-0.747661	11.227190!sample_table_end